Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
- PMID: 27330887
- PMCID: PMC4870532
- DOI: 10.1186/s40064-016-2283-5
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
Abstract
Background: Survivin is a newly found member of the inhibitors of apoptosis proteins, which plays a certain role in cancer. Survivin has a distinctly different expression in cancers, including prostate cancer. We are searching for the relationship between survivin levels in normal prostate tissue, benign prostate hyperplasia (BPH), and prostate adenocarcinoma in this study.
Results: The study surveyed 282 prostate samples, 94 normal, 94 BPH, and 94 prostate adenocarcinoma samples. Survivin expression was absent in normal prostate tissues. In the BPH group, the survivin expression level was higher than that of the normal group. In the adenocarcinoma group, the survivin expression level was higher than that of the BPH group. There was a significant association between survivin expression level and the adenocarcinoma stage.
Conclusion: Although there is no expression of survivin in normal prostate tissue, its expression is slightly positive in BPH. High survivin expression is related to a higher Gleason score in the adenocarcinoma of the prostate.
Figures


Similar articles
-
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.J Urol. 2005 Nov;174(5):2046-50. doi: 10.1097/01.ju.0000176459.79180.d1. J Urol. 2005. PMID: 16217391
-
Differences in CD24 Expression Between Prostate Adenocarcinoma and Benign Prostatic Hyperplasia: A Cross-sectional Study.Iran J Pathol. 2024;19(3):306-310. doi: 10.30699/ijp.2024.2021959.3251. Epub 2024 Jul 24. Iran J Pathol. 2024. PMID: 39687458 Free PMC article.
-
Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.Prostate. 2009 Sep 1;69(12):1292-302. doi: 10.1002/pros.20973. Prostate. 2009. PMID: 19462463
-
Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.Am J Surg Pathol. 2011 Jul;35(7):1054-61. doi: 10.1097/PAS.0b013e318218df97. Am J Surg Pathol. 2011. PMID: 21606823
-
Localization and upregulation of survivin in cancer health disparities: a clinical perspective.Biologics. 2015 Jul 9;9:57-67. doi: 10.2147/BTT.S83864. eCollection 2015. Biologics. 2015. PMID: 26185415 Free PMC article. Review.
Cited by
-
Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.Int J Mol Sci. 2017 Mar 22;18(3):680. doi: 10.3390/ijms18030680. Int J Mol Sci. 2017. PMID: 28327526 Free PMC article.
-
Considering the potential for gene-based therapy in prostate cancer.Nat Rev Urol. 2021 Mar;18(3):170-184. doi: 10.1038/s41585-021-00431-x. Epub 2021 Feb 26. Nat Rev Urol. 2021. PMID: 33637962 Review.
-
Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an in silico analysis.EXCLI J. 2018 May 18;17:479-491. doi: 10.17179/excli2018-1234. eCollection 2018. EXCLI J. 2018. PMID: 30034311 Free PMC article.
-
Assessment of Relationship Between Expression of Survivin Protein and Histopathology Diagnosis and Malignancy Severity in Colon Specimen.J Gastrointest Cancer. 2020 Mar;51(1):76-82. doi: 10.1007/s12029-019-00206-z. J Gastrointest Cancer. 2020. PMID: 30714071
-
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer.Sci Rep. 2020 Feb 24;10(1):3250. doi: 10.1038/s41598-020-60064-9. Sci Rep. 2020. PMID: 32094363 Free PMC article.
References
-
- Dabbs DJ. Diagnostic immunohistochemistry. 4. Amsterdam: Elsevier Health Sciences; 2013.
-
- de Almagro MC, Vucic D. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Experimental oncology. 2012;34(3):200–211. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources